Nagel, Zachary D; Engelward, Bevin P; Brenner, David J et al. (2017) Towards precision prevention: Technologies for identifying healthy individuals with high risk of disease. Mutat Res 800-802:14-28
|
Meyer, Sara E; Peace, Belinda E; Bahassi, El Mustapha et al. (2010) Chk2*1100delC Acts in synergy with the Ron receptor tyrosine kinase to accelerate mammary tumorigenesis in mice. Cancer Lett 296:186-93
|
Chen, Yinhuai; Caldwell, Julie M; Pereira, Elizabeth et al. (2009) ATRMec1 phosphorylation-independent activation of Chk1 in vivo. J Biol Chem 284:182-90
|
Pereira, Elizabeth; Chen, Yinhuai; Sanchez, Yolanda (2009) Conserved ATRMec1 phosphorylation-independent activation of Chk1 by single amino acid substitution in the GD domain. Cell Cycle 8:1788-93
|
Bahassi, El Mustapha; Robbins, Susan B; Yin, Moying et al. (2009) Mice with the CHEK2*1100delC SNP are predisposed to cancer with a strong gender bias. Proc Natl Acad Sci U S A 106:17111-6
|
Doetschman, Thomas (2009) Influence of genetic background on genetically engineered mouse phenotypes. Methods Mol Biol 530:423-33
|
Chen, Kesi; Ohkubo, Yasushi; Shin, Dana et al. (2008) Decrease in excitatory neurons, astrocytes and proliferating progenitors in the cerebral cortex of mice lacking exon 3 from the Fgf2 gene. BMC Neurosci 9:94
|
Caldwell, Julie M; Chen, Yinhuai; Schollaert, Kaila L et al. (2008) Orchestration of the S-phase and DNA damage checkpoint pathways by replication forks from early origins. J Cell Biol 180:1073-86
|
Busuttil, Rita A; Lin, Qingcong; Stambrook, Peter J et al. (2008) Mutation frequencies and spectra in DNA polymerase eta-deficient mice. Cancer Res 68:2081-4
|
Bahassi, E M; Ovesen, J L; Riesenberg, A L et al. (2008) The checkpoint kinases Chk1 and Chk2 regulate the functional associations between hBRCA2 and Rad51 in response to DNA damage. Oncogene 27:3977-85
|
Showing the most recent 10 out of 28 publications